Here’s a horror show of a story that you’re probably not going to see on CNN anytime soon. A report emerged on Thursday indicating that the puberty-blocking drug Leuprolide Acetate (Lupron) has resulted in tens of thousands of serious “adverse reactions” in patients, including more than six thousand deaths. That’s bad enough, but it’s even more significant when you consider that this is one of the drugs being administered by doctors to so-called “transgender children” to unnaturally prevent their normal sexual development. And the testing done on the drug by the FDA for such applications appears to be thin at best. (Daily Wire)

More than 6,300 adults have died from reactions to a drug that is used as a puberty blocker in gender-confused children, Food & Drug Administration data reportedly shows.

“Between 2012 and June 30 of this year, the FDA documented over 40,764 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 25,500 reactions logged from 2014-2019 were considered ‘serious,’ including 6,370 deaths,” The Christian Post reported on Thursday.

“Lupron is being prescribed off-label for use in children who have been diagnosed with gender dysphoria despite the lack of formal FDA approval for that purpose,” the outlet explained.

You can do a search of the FDA’s incident reports here and enter the name of the drug (Lupron) to see their data.

Despite the possible adverse side effects, there are approved uses for Lupron, but it tends to be administered only for serious conditions. It’s useful in treating prostate cancer in men and endometriosis in women. For children, it is sometimes used to treat precocious puberty, a condition where children begin puberty at an unusually early age, but only for a short time.

The list of potential side effects for the drug is alarming. It includes breast disorders, malignant neoplasms, and psychiatric and nervous disorders. Stop and think about that for a moment. If you have a child that is already so confused that they are questioning their “gender identity” before they’ve even reached the age where their body is dealing with such issues, do you want to give them a drug that can produce psychiatric or nervous disorders?

To top it all off, the FDA has never formally approved the use of Lupron for treating gender dysphoria in children. Two years ago the agency announced that it was beginning a study of “nervous system and psychiatric events in association with the use of … a class of drugs including Lupron, in pediatric patients.” We don’t know the results of that study yet.

What adults, including transgender individuals, choose to do with their own bodies is their business as long as they’re willing to take responsibility for the results. But the experiments being performed on confused young children who have been convinced that they were somehow born the “wrong gender” are simply monstrous. Blocking the natural arrival of puberty in otherwise healthy children should be considered child abuse and medical malpractice to begin with. All of the questions raised in this report about one of the drugs being administered to do such things makes it all the worse.